AIM
AIM ImmunoTech
AIM ImmunoTech Inc. (AMEX: AIM), formerly known as Hemispherx Biopharma Inc., is a biopharmaceutical company based in Ocala, Florida. Founded in 1990, the company has 32 employees.
Index: NYSE; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 84.14M; Volume: 159.51K; AvgVol 3m: 5.70M; Beta: -0.97;
Cost estimate:
P/E: –; EPS: -1.49; EPS growth quarter/prev quarter: 89.50%;
EPS growth this year: 73.20%; EPS growth past 5 years: 44.30%;
EPS ttm: -1.49;
P/S: 433.61; P/B: 1.49; P/Cashflow: 2.48; P/FCF: ;
Sales: 190.00K; Sales growth quarter/prev quarter: 37.90%; Sales growth past 5 years: -6.60%;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -33.40%; ROE – return on equity: -42.70%; LT Debt/Equity: 0.04; Total Debt/Equity: 0.05;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.50%; Insider Transactions:13.86%;
Institutional Ownership: 4.70%; Institutional Transactions: 295.63%;
Data update: 07.10.2020.